Table 2.

Relationship between mycobacterial IgG positivity and interferon-beta (IFN) therapy.

		features		OR	95%CI	p
		IFN-beta neg	IFN-beta pos	34
MS (n = 51)	MAP IgG pos	4	5	11.9	2.2–63	0.004*
	MAP IgG neg	38	4
		IFN-beta neg	IFN-beta pos
MS (n = 51)	BCG IgG pos	4	0	1.6	0.1–17	0.6
	BCG IgG neg	39	8

MS, multiple sclerosis; NMOSD, neuromyelitis optica spectrum disorders; OR, odds ratio; CI, confidence interval; * statistically significant.